Mizuho Securities USA LLC lowered its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 15.0% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 12,377 shares of the semiconductor company's stock after selling 2,182 shares during the period. Mizuho Securities USA LLC's holdings in Synopsys were worth $5,308,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in SNPS. Brighton Jones LLC raised its position in Synopsys by 5.7% in the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock valued at $447,000 after buying an additional 50 shares during the last quarter. Argent Trust Co raised its holdings in shares of Synopsys by 8.9% in the fourth quarter. Argent Trust Co now owns 833 shares of the semiconductor company's stock valued at $404,000 after purchasing an additional 68 shares during the last quarter. Sterling Capital Management LLC raised its holdings in shares of Synopsys by 2.6% in the fourth quarter. Sterling Capital Management LLC now owns 9,973 shares of the semiconductor company's stock valued at $4,840,000 after purchasing an additional 256 shares during the last quarter. Rockefeller Capital Management L.P. lifted its position in shares of Synopsys by 8.1% during the fourth quarter. Rockefeller Capital Management L.P. now owns 24,418 shares of the semiconductor company's stock valued at $11,859,000 after purchasing an additional 1,836 shares in the last quarter. Finally, Optimize Financial Inc purchased a new position in Synopsys during the fourth quarter worth about $1,784,000. 85.47% of the stock is owned by institutional investors.
Synopsys Trading Down 0.1%
Shares of Synopsys stock opened at $619.42 on Friday. The stock has a market capitalization of $96.11 billion, a P/E ratio of 44.72, a P/E/G ratio of 4.10 and a beta of 1.15. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a debt-to-equity ratio of 1.01, a quick ratio of 6.85 and a current ratio of 7.02. The stock's 50-day simple moving average is $544.48 and its 200 day simple moving average is $494.74.
Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.40 by $0.27. Synopsys had a net margin of 34.77% and a return on equity of 17.09%. The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.60 billion. During the same quarter in the previous year, the firm posted $3.00 earnings per share. The company's quarterly revenue was up 10.3% compared to the same quarter last year. As a group, research analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.
Wall Street Analyst Weigh In
SNPS has been the subject of several analyst reports. The Goldman Sachs Group assumed coverage on shares of Synopsys in a research note on Thursday, July 10th. They issued a "buy" rating and a $620.00 price objective for the company. Mizuho decreased their price target on Synopsys from $650.00 to $600.00 and set an "outperform" rating for the company in a research report on Tuesday, April 15th. KeyCorp boosted their price objective on Synopsys from $540.00 to $610.00 and gave the stock an "overweight" rating in a research report on Thursday, July 10th. Rosenblatt Securities raised their target price on Synopsys from $625.00 to $650.00 and gave the company a "buy" rating in a research report on Friday, July 25th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $660.00 target price (up from $650.00) on shares of Synopsys in a research note on Tuesday, July 15th. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $622.33.
View Our Latest Research Report on Synopsys
Insider Transactions at Synopsys
In other Synopsys news, CFO Shelagh Glaser sold 7,310 shares of Synopsys stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $485.72, for a total transaction of $3,550,613.20. Following the completion of the transaction, the chief financial officer owned 15,291 shares of the company's stock, valued at $7,427,144.52. The trade was a 32.34% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Sassine Ghazi sold 11,366 shares of the company's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $457.93, for a total value of $5,204,832.38. Following the sale, the chief executive officer owned 71,589 shares in the company, valued at approximately $32,782,750.77. This represents a 13.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 27,686 shares of company stock valued at $13,001,048 over the last three months. Company insiders own 0.62% of the company's stock.
About Synopsys
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.